Beth has served as lead counsel in over 50 jury trials, including numerous bet-the company, multibillion-dollar cases. She has developed an unrivaled record of victories in federal and state courts throughout the country. Her career has taken Beth from the Army to a leading role in the prosecution of the Oklahoma City bombers to nationally recognized work as a litigation partner at two of the nation’s most prominent law firms, and to founding Wilkinson Stekloff.
Most recently, Beth led the trial team that secured judgment as a matter of law for the NFL and its 32 member teams in a class action lawsuit challenging the distribution of the Sunday Ticket subscription package and the NFL’s media agreements more generally. Beth delivered opening and closing statements and conducted direct examinations of several key NFL witnesses, including Commissioner Roger Goodell and Dallas Cowboys Owner Jerry Jones. Beth also cross-examined one of the plaintiffs’ key expert witnesses, laying the groundwork for the post-trial Daubert ruling excluding the testimony as unreliable and resulting in a complete victory for the NFL.
Beth also recently served as lead trial counsel for Microsoft in the FTC’s challenge to Microsoft’s $68.7 billion acquisition of Activision — the second-largest merger trial in American history. She directed all aspects of litigation strategy from the time the acquisition was announced in January 2022, positioning the case for victory on an unprecedented timetable, defeating the FTC’s preliminary injunction request after a five-day trial that began less than two weeks after the FTC filed its federal court complaint. The American Lawyer named Beth “Litigator of the Week” and described the firm as “the legal equivalent of an elite special ops unit” for leading the successful defense.
Beth is a Fellow of the American College of Trial Lawyers and a member of The American Law Institute. In 2025, she received Bloomberg Law’s “Unrivaled” award, the inaugural celebration of the most impactful high-stakes litigators in the
country, and was recognized by Global Competition Review as one of the elite “Women in Antitrust.” Chambers honored Beth with its national “Outstanding Individual” award in 2024, and Legal 500 inducted her into its Hall of Fame in 2022. She has been named American Lawyer “Litigator of the Year,” a Law360 “Trial Ace” and “Trial MVP,” a National Law Journal “Winning Litigator” and “General Litigation Trailblazer,” and one of Washingtonian’s “Most Powerful Women in Washington.” In addition, Chambers has repeatedly named Beth a “Star Trial Lawyer,” describing Beth as “the best trial lawyer there is,” a “superstar,” and a “lion at the bar.” Beth has also been chosen for Benchmark’s select group of the 10 leading women litigators who stand out from its iconic “Top 250 Women in Litigation” list, as well as Benchmark’s list of “Top 100 Trial Lawyers.”
Beth’s other notable representations include:
- Lead trial counsel for Altria Group, Inc. in an administrative trial related to the FTC’s challenge of Altria’s $12.8 billion minority investment in JUUL Labs. Obtained a full dismissal of claims against Altria by the FTC’s Chief Administrative Law Judge. Also lead counsel for Altria in putative class action antitrust lawsuits pending in the Northern District of California related to the JUUL Labs investment.
- Lead trial counsel for Bayer in the multi-district litigation involving the blood-thinner Xarelto, and in the first Xarelto state court trial. She obtained complete defense verdicts in two MDL bellwether trials and judgment for Bayer notwithstanding a plaintiff’s verdict in the state court bellwether.
